← Back to Search

Computer-Assisted Stop-Smoking Program for Tobacco Use Disorder

Phase 2

Waitlist Available

Led By Theodore W. Marcy, MD, MPH

Research Sponsored by University of Vermont

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Study Summary

This trial is testing a stop-smoking program to see if it helps doctors better counsel patients who smoke cigarettes.

Who is the study for?

This trial is for current smokers who are patients at Fletcher Allen Health Care primary care clinics. It's designed to help them quit smoking with the assistance of their doctors and a computer program.Check my eligibility

What is being tested?

The study is testing a phase II computer-assisted stop-smoking program. The goal is to see if this technology can improve how doctors counsel patients on quitting smoking, potentially increasing success rates.See study design

What are the potential side effects?

Since this trial involves counseling and computer programs rather than medication, there are no direct medical side effects. However, participants may experience stress or anxiety related to attempting to quit smoking.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Aggregate data on accessing SC-PDA screens by each physician as measured by the SC-PDA server log

Clinic staff opinion on the effect of SC-PDA on clinic workflow as measured by clinic staff focus groups

Generation of patient handouts as measured by the SC-PDA server log, clinic staff focus groups, and telephone interview

+7 more

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,651 Previous Clinical Trials

40,932,300 Total Patients Enrolled

93 Trials studying Tobacco Use Disorder

1,682,200 Patients Enrolled for Tobacco Use Disorder

University of VermontLead Sponsor

266 Previous Clinical Trials

3,743,061 Total Patients Enrolled

14 Trials studying Tobacco Use Disorder

5,120 Patients Enrolled for Tobacco Use Disorder

Theodore W. Marcy, MD, MPHPrincipal InvestigatorUniversity of Vermont

Media Library

Treatment Clinical Trial Eligibility Overview. Trial Name: NCT00865553 — Phase 2

Tobacco Use Disorder Research Study Groups:

Tobacco Use Disorder Clinical Trial 2023: Treatment Highlights & Side Effects. Trial Name: NCT00865553 — Phase 2

Treatment 2023 Treatment Timeline for Medical Study. Trial Name: NCT00865553 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are we still able to enroll in this clinical research?

"The clinical trial in question is no longer recruiting patients, as reported on the government website. This specific study was posted on March 1st, 2009 and last updated September 19th, 2013. There are other ongoing trials that may be of interest; 117 studies are actively enrolling participants at this time."

Answered by AI

Will this treatment help patients without putting them in danger?

"This phase 2 trial lacks data supporting efficacy, but there is some safety information available. Our team at Power consequently gave it a score of 2."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Computer-Assisted Stop-Smoking Program in Helping Doctors Counsel Patients Who Smoke Cigarettes

2009. "Computer-Assisted Stop-Smoking Program in Helping Doctors Counsel Patients Who Smoke Cigarettes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00865553.

All > Vermont > Smoking